The Trump administration has promised that addressing childhood obesity will be a key part of its “Make America Healthy Again ...

An expert Cleveland Clinic doctor reveals how much weight you can safely lose in a month and strategies to help you achieve ...

(HealthDay News) — Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those ...

Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Central obesity measures of waist circumference and waist-to-hip ratio appear to be more accurate and consistent indicators ...

That support doesn't go for teens. More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss ...

‘Given that weight reduction decreases obesity-induced inflammation, a key factor believed to mediate the link between obesity and MS, our study emphasises the importance of preventing high ...

However, that diabetes drug was shown to cause weight loss, which was when the market blew up. Obesity is arguably the biggest health phenomenon worldwide. The global prevalence of obesity more ...

The online market for obesity drugs has boomed in the UK ... against at least a dozen online pharmacies over their supply of weight-loss medicines, she said. The guidance requires online ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...